Speaker events at the Congress in Washington, DC, last week included discussion on two current pressing issues.
The first examined issues around pharma companies choosing speakers for their sponsored events. There are strict guidelines that need to be followed under regulatory agencies such as HHS-OIG.
“There has to be a